Cytokines as Diagnostic Markers of Pulpal Inflammation and Their Impact on the Outcome of Vital Pulp Therapy (Pulp Therapy)

November 28, 2025 updated by: Mohamed Khalifa, Mansoura University
intervention eligible patients with teeth diagnosed with reversible or irreversible pulpits will go for vital pulp therapy and the other group will be patients will go for extraction of caries free teeth for orthodontic reasons, blood samples will be collected from both groups to analyze the level of cytokines IL-8 and IL-10 and it's relation with the success of the pulp therapy

Study Overview

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Al Mansurah, Egypt
        • Faculty of Dentistry, Mansoura Univeristy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • The age ranges from 16-45 years medically free.
  • Tooth should be vital on cold testing.
  • Vital permanent premolar and molar on cold testing, with deep caries, subsequent pulp exposure and bleeding pulp tissue in all canals after complete pulpotomy.
  • Diagnosis is either reversible or irreversible pulpitis with/ without periapical rarefaction.
  • The tooth is restorable and free from advanced periodontal disease.
  • Soft tissues around the tooth are normal with no swelling or sinus tract.

Exclusion Criteria:

  • Patients over 45 years of age.
  • Patients with clinical symptoms of periradicular inflammation or any periradicular radiographic lesions.
  • Negative results for cold and electrical pulp testing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Molars or premolars with Reversible or irreversible pulpits
fifteen patients with carious teeth showing signs and symptoms of pulp inflammation
  1. Full medical and dental history will be taken from each patient.
  2. Clinical and radiographic examination (Cone beam computed tomography) for the offending tooth.
  3. After anesthesia, Rubber dam is applied and complete caries removal will be done, deeply inside the cavity, the excavation will be done using low speed hand piece and excavator.
  4. A blood sample will be taken from the bleeding pulp tissue on a cotton pellet for Molecular test.
  5. After exposure, the pulp will be amputated to the level of the canal orifices (full pulpotomy) pulp vitality was confirmed by the presence of bleeding pulp tissue from all canals.
  6. Putty MTA will gently place over the pulp.
  7. The cavity will be sealed with initial deep layer of resin modified glass ionomer restoration (RMGI) and final superficial layer of composite restoration.
after access opening blood sample will be collected
Active Comparator: Caries free molars or premolars
fifteen patients with intact human premolars planed for extraction for orthodontic reason
after access opening blood sample will be collected
  1. Full medical and dental history will be taken from each patient.
  2. Clinical and radiographic examination (Cone beam computed tomography) for the offending tooth.
  3. After anesthesia, Rubber dam is applied.
  4. A blood sample will be taken from the bleeding pulp tissue on a cotton pellet for Molecular test.
  5. Extraction for orthodontic reasons.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical success
Time Frame: one day, one, four and twelve weeks.
post operative pain on cold testing binary outcome (Yes or no)
one day, one, four and twelve weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiographic success
Time Frame: Pre-operative , and after six months
Cone Beam Computed Tomography CBCT radiographic Examination for any periodontal widening or any periapical radiolucency.
Pre-operative , and after six months
level of cytokines
Time Frame: through study completion, an average of 6 months
level of Interleukin 8 and Interleukin 10 will be measured using Enzyme- Linked Immunosorbent assay (ELISA) Kit
through study completion, an average of 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2022

Primary Completion (Actual)

October 1, 2024

Study Completion (Actual)

April 2, 2025

Study Registration Dates

First Submitted

November 19, 2025

First Submitted That Met QC Criteria

November 28, 2025

First Posted (Estimated)

December 3, 2025

Study Record Updates

Last Update Posted (Estimated)

December 3, 2025

Last Update Submitted That Met QC Criteria

November 28, 2025

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • M05060722

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Irreversible Pulpitis

Clinical Trials on Vital pulp therapy

Subscribe